As researchers progress towards clinically relevant processes ... to receive step-by-step guidance about optimizing and standardizing scalable lentiviral vector production and clarification.

They engineered an adenoviral vector to include a repressor protein ... other advantages over alternative ‘helper-free’ rAAV manufacturing systems. “For all the serotypes tested, we ...

Reports FY24 revenue GBP 128.8M vs. GBP 89.5M last year. Frank Mathias, CEO of OXB, commented: “2024 was a year of strong commercial progress for ...